BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 12, 2024

Total Value: $4.71B (100.0% shares, 0.0% debt)

Holdings (5)

— CEREVEL THERAPEUTICS HLDNG I 57.0%

Value $2.686B Shares 65,679,781 Share Price $40.89 Est. Cost/Share — Unrealized @ Report Date —

SGRY SURGERY PARTNERS INC 25.2%

Value $1.188B Shares 49,946,972 Share Price $23.79 Est. Cost/Share — Unrealized @ Report Date —

WAY WAYSTAR HLDG CORP 12.8%

Value $602M Shares 27,980,417 Share Price $21.50 Est. Cost/Share — Unrealized @ Report Date —

AVAH AVEANNA HEALTHCARE HLDGS INC 4.8%

Value $225M Shares 81,600,880 Share Price $2.76 Est. Cost/Share — Unrealized @ Report Date —

ADV ADVANTAGE SOLUTIONS INC 0.2%

Value $9.306M Shares 2,890,000 Share Price $3.22 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	CEREVEL THERAPEUTICS HLDNG I	65,679,781	$2.686B	57.0%	$40.89	—	—	COM	15678U128
SGRY	SURGERY PARTNERS INC	49,946,972	$1.188B	25.2%	$23.79	—	—	COM	86881A100
WAY	WAYSTAR HLDG CORP	27,980,417	$602M	12.8%	$21.50	—	—	COM	946784105
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,600,880	$225M	4.8%	$2.76	—	—	COM	05356F105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$9.306M	0.2%	$3.22	—	—	COM CL A	00791N102